Rate of Pregnancy After Using Drospirenone and Other Progestin-Containing Oral Contraceptives
- 1 September 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Obstetrics & Gynecology
- Vol. 114 (3), 616-622
- https://doi.org/10.1097/aog.0b013e3181b46f54
Abstract
To determine whether prior oral-contraceptive use has a negative effect on the ability of women to conceive in both the short-term and long-term. The European Active Surveillance Study on Oral Contraceptives (EURAS-OC) was a controlled, prospective, noninterventional cohort study of 59,510 users of oral contraceptives containing drospirenone or other progestins in clinical practice in seven European countries. In a planned secondary analysis, pregnancy outcomes were investigated in 2,064 participants in EURAS-OC who stopped oral-contraceptive use after study entry because of planned pregnancy. The influence of age, parity, progestin type, ethinylestradiol dose, duration of oral-contraceptive use, and smoking status on the rate of pregnancy was assessed. Overall, 21.1% (95% confidence interval [CI] 19.4-23.0%) of the past oral-contraceptive users were pregnant one cycle after oral-contraceptive cessation. This rate increased to 79.4% (95% CI 77.6-81.1%) at 1 year (13 cycles). Progestin type, ethinylestradiol dose, duration of oral-contraceptive use, and parity had no major influence on the rate of pregnancy after oral-contraceptive cessation. Up to age 35 years, age had only a minor influence on the rate of pregnancy. Rates of pregnancy were reduced in women older than 35 years and in current smokers. Previous oral-contraceptive use does not negatively affect initial and 1-year rates of pregnancy after oral-contraceptive cessation. A comparison of these data with data external to this study indicates that the negative effect of aging on fecundity is not amplified by oral-contraceptive use. II.Keywords
This publication has 15 references indexed in Scilit:
- The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observationContraception, 2007
- Fertility after discontinuation of treatment with an oral contraceptive containing 30 μg of ethinyl estradiol and 2 mg of dienogestFertility and Sterility, 2006
- Is previous use of hormonal contraception associated with a detrimental effect on subsequent fecundity?Human Reproduction, 2004
- Increased Infertility With Age in Men and WomenObstetrics & Gynecology, 2004
- Safety of a New Oral Contraceptive Containing DrospirenoneDrug Safety, 2004
- An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogenContraception, 2000
- A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrelThe European Journal of Contraception & Reproductive Health Care, 2000
- Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenoneThe European Journal of Contraception & Reproductive Health Care, 2000
- Effects of age, cigarette smoking, and other factors on fertility: findings in a large prospective study.BMJ, 1985
- Fertility after stopping different methods of contraception.BMJ, 1978